Researcher.Life Logo

Ophthalmology and Therapy : Impact Factor & More

eISSN: 2193-6528pISSN: 2193-8245
JournalOpen Access

Key Metrics

CiteScore
4.8
Impact Factor
< 5
SJR
Q1Ophthalmology
SNIP
1.7
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Ophthalmology and Therapy

Ophthalmology and Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SPRINGER INT PUBL AG
Language English
Frequency Semi-annual
Article Processing ChargesEUR 5500 | USD 6850 | GBP 4700
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencySemi-annual
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Ophthalmology and Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Ophthalmology and Therapy

Safety and Feasibility of the Exchange Procedure for the Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension.
  • 14 Mar 2026
  • Ophthalmology and therapy
Report Generation System for Slit-Lamp Image Interpretation Using Vision-Language Models.
  • 14 Mar 2026
  • Ophthalmology and therapy
Lower Rates of Intraocular Inflammation with Aflibercept 8mg Delivered via Pre-Filled Syringe Versus Vial.
  • 14 Mar 2026
  • Ophthalmology and therapy
Ocular Half-Life: What it Does and Does Not Mean for Intravitreal Anti-angiogenic Drug Durability.
  • 13 Mar 2026
  • Ophthalmology and therapy
Immunomodulation of the Ocular Surface in Severe Dry Eye Disease: Expert-Driven Literature Review on Treatment Strategies with Description of Representative Challenging Cases.
  • 13 Mar 2026
  • Ophthalmology and therapy
Randomized, Controlled Study to Evaluate the Safety and Efficacy of Oxygen-Enriched Epithelium-On Corneal Cross-Linking for the Treatment of Keratoconus.
  • 13 Mar 2026
  • Ophthalmology and therapy
Safety and Feasibility of the Exchange Procedure for the Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension.
  • 14 Mar 2026
  • Ophthalmology and therapy
Report Generation System for Slit-Lamp Image Interpretation Using Vision-Language Models.
  • 14 Mar 2026
  • Ophthalmology and therapy
Lower Rates of Intraocular Inflammation with Aflibercept 8mg Delivered via Pre-Filled Syringe Versus Vial.
  • 14 Mar 2026
  • Ophthalmology and therapy
Ocular Half-Life: What it Does and Does Not Mean for Intravitreal Anti-angiogenic Drug Durability.
  • 13 Mar 2026
  • Ophthalmology and therapy
Immunomodulation of the Ocular Surface in Severe Dry Eye Disease: Expert-Driven Literature Review on Treatment Strategies with Description of Representative Challenging Cases.
  • 13 Mar 2026
  • Ophthalmology and therapy
Randomized, Controlled Study to Evaluate the Safety and Efficacy of Oxygen-Enriched Epithelium-On Corneal Cross-Linking for the Treatment of Keratoconus.
  • 13 Mar 2026
  • Ophthalmology and therapy

FAQs on Ophthalmology and Therapy